MELINTA THERAPEUTICS, INC
–
Parsippany, NJ, 07054
... Melinta's current portfolio includes seven commercial stage products and one investigational product under review by FDA: BAXDELA (delafloxacin), KIMYRSA (oritavancin), MINOCIN (minocycline) for Injection, ORBACTIV (oritavancin), REZZAYO (rezafungin ... - Jun 11